BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. (NYSE:DCF – Get Rating) was the recipient of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 8,300 shares, an increase of 207.4% from the March 31st total of 2,700 shares. Based on an average daily volume of 33,500 shares, the days-to-cover ratio is presently 0.2 days.
Shares of DCF stock opened at $8.43 on Thursday. BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund has a one year low of $8.13 and a one year high of $9.99. The stock has a fifty day moving average price of $8.45 and a 200 day moving average price of $9.01.
The company also recently announced a monthly dividend, which was paid on Monday, April 25th. Investors of record on Friday, April 8th were given a $0.05 dividend. The ex-dividend date of this dividend was Thursday, April 7th. This represents a $0.60 annualized dividend and a yield of 7.12%.
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Company Profile (Get Rating)
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc operates as a closed-end investment fund. The fund’s investment objective is to seek high current income and to invest in credit instruments and other investments. The company is headquartered in New York, NY.
Read More
- Get a free copy of the StockNews.com research report on BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund (DCF)
- Automatic Data Processing Is Ready To Scale New HeightsÂ
- Carl Icahn Buys More Xerox
- Xerox Holdings Stock is a Value Play
- The Kraft Heinz Turnaround Story Gains MomentumÂ
- Microsoft (NASDAQ: MSFT) Saves The Day, For Now
Receive News & Ratings for BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund and related companies with MarketBeat.com's FREE daily email newsletter.